NASDAQ: PEPGPepgen Inc Stock Ownership - Who owns Pepgen?
Insider buying vs selling
Have Pepgen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul Streck | EVP Head of RD | 2026-03-04 | 47 | $6.29 | $295.54Sell |
| Noel Donnelly | Chief Financial Officer | 2026-03-04 | 52 | $6.33 | $328.90Sell |
| James G. McArthur | President and CEO | 2026-03-04 | 5,144 | $6.23 | $32.05kSell |
| James G. McArthur | President and CEO | 2026-03-04 | 131 | $6.33 | $828.58Sell |
| Paul Streck | EVP Head of RD | 2026-03-04 | 1,832 | $6.23 | $11.41kSell |
| Noel Donnelly | Chief Financial Officer | 2026-03-04 | 2,032 | $6.23 | $12.66kSell |
| Oxford Science Enterprises PLC | Insider | 2025-09-30 | 200,000 | $3.20 | $640.00kBuy |
| Ra Capital Management LP | Director | 2025-09-26 | 9,375,000 | $3.20 | $30.00MBuy |
| Paul Streck | EVP Head of RD | 2025-05-30 | 8,375 | $1.24 | $10.39kBuy |
| James G. McArthur | President and CEO | 2025-04-17 | 10,000 | $1.36 | $13.55kBuy |
PEPG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PEPG insiders and whales buy or sell their stock.
PEPG Shareholders
What type of owners hold Pepgen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 29.03% | 20,064,545 | $111.76M | Institution |
| Oxford Science Enterprises PLC | 7.17% | 4,955,388 | $27.60M | Insider |
| Viking Global Investors LP | 5.04% | 3,482,434 | $19.40M | Institution |
| Commodore Capital LP | 4.92% | 3,400,000 | $18.94M | Institution |
| Vivo Capital LLC | 3.36% | 2,325,000 | $12.95M | Institution |
| Point72 Asset Management LP | 3.29% | 2,274,416 | $12.67M | Institution |
| Vanguard Group Inc | 3.20% | 2,212,834 | $12.33M | Institution |
| Laurion Capital Management LP | 2.97% | 2,052,133 | $11.43M | Institution |
| Bvf Inc | 2.77% | 1,915,000 | $10.67M | Institution |
| Nantahala Capital Management LLC | 2.24% | 1,547,229 | $8.62M | Institution |
PEPG vs Biotech Stocks
Pepgen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.